EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human Leukocyte Antigen-DR Expression on Monocytes Is a Useful Predictor in a Systemic Inflammation Response-Based Prognostic Model in Advanced Non-Small Cell Lung Cancer

Gergő Szűcs iD, András Gézsi, Márton Szentkereszty iD, György Losonczy, Gábor Barna iD, Gabriella Gálffy, Anikó Bohács, Lilla Tamási, Veronika Müller iD, Edit I Buzás, Zsolt I Komlósi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Gergő Szűcs und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonolgy, Semmelweis University, 1089 Budapest, Hungary. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Monocytes, HLA-DR Antigens, Lung Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Scientific Research, National Cardiovascular Laboratory, the NKFIH Advanced Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation and immune evasion promote tumorigenesis and progression. Elevated systemic inflammation response index (SIRI) is associated with poor progression-free survival (PFS) and overall survival (OS) in non-small cell lung cancer (NSCLC) patients. Low Human Leukocyte Antigen-DR (HLA-DR) expression on monocytes is also associated with poor prognosis in NSCLC. We aimed to investigate the relationship between these two indicators and develop a predictive model based on them. SIRI was calculated and monocyte HLA-DR expression was measured by flow cytometry in 58 advanced (stage IIIB-IV) NSCLC patients. The log-rank test and multivariate Cox proportional hazard regression model were used for analysis. We confirmed that both high SIRI and low monocyte HLA-DR expression were associated with poor PFS and OS, respectively. We found a significant inverse correlation between SIRI and monocyte HLA-DR expression. In the multivariable Cox regression model, both SIRI and monocyte HLA-DR expression were identified as independent prognostic markers for PFS and OS. We also developed a nomogram for predicting PFS and OS. In conclusion, we demonstrated that the systemic inflammation response of advanced NSCLC patients, estimated by SIRI, was associated with reduced HLA-DR expression on circulating monocytes, which may influence their antigen-presenting function. Consequently, the integration of these two biomarkers into one prognostic model improves short term survival prediction in advanced NSCLC. To our knowledge, this is the first integration of SIRI and HLA-DR into a combined prognostic nomogram.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungMonocytesHLA-DR AntigensLung NeoplasmsInflammationHumansFemaleMaleMiddle AgedPrognosisAgedBiomarkers, TumorAdultProportional Hazards Models

Stichwörter der Autor:innen

HLA-DRnomogram modelnon-small cell lung cancersystemic inflammation response index

Substanzen

HLA-DR AntigensBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pulmonolgy, Semmelweis University, 1089 Budapest, Hungary.
  • Institute of Genetics, Cell- and Immunobiology, Semmelweis University, 1089 Budapest, Hungary.
  • Department of Artificial Intelligence and Systems Engineering, University of Technology and Economics, 1117 Budapest, Hungary.
  • Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Pulmonology Center of the Reformed Church in Hungary, 2045 Törökbálint, Hungary.
  • HCEMM-SU Extracellular Vesicle Research Group, 1089 Budapest, Hungary.

ORCID-Profile: Gergő Szűcs, Márton Szentkereszty, Gábor Barna, Veronika Müller, Zsolt I Komlósi

Förderung

  • Hungarian Scientific Research
  • National Cardiovascular Laboratory
  • the NKFIH Advanced Grant
  • Hungarian Scientific Research Fund
  • NKFIH Advanced Grant

Zitieren

APA

Szűcs, G., Gézsi, A., Szentkereszty, M., Losonczy, G., Barna, G., Gálffy, G., Bohács, A., Tamási, L., Müller, V., Buzás, E. I., & Komlósi, Z. I. (2025). Human Leukocyte Antigen-DR Expression on Monocytes Is a Useful Predictor in a Systemic Inflammation Response-Based Prognostic Model in Advanced Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189226

Vancouver

Szűcs G, Gézsi A, Szentkereszty M, Losonczy G, Barna G, Gálffy G, et al. Human Leukocyte Antigen-DR Expression on Monocytes Is a Useful Predictor in a Systemic Inflammation Response-Based Prognostic Model in Advanced Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189226

BibTeX
@article{Szcs2025,
  author = {Szűcs, Gergő and Gézsi, András and Szentkereszty, Márton and Losonczy, György and Barna, Gábor and Gálffy, Gabriella and Bohács, Anikó and Tamási, Lilla and Müller, Veronika and Buzás, Edit I and Komlósi, Zsolt I},
  title = {Human Leukocyte Antigen-DR Expression on Monocytes Is a Useful Predictor in a Systemic Inflammation Response-Based Prognostic Model in Advanced Non-Small Cell Lung Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189226}
}
Kostenlos starten →